ATE384046T1 - Verfahren zur asymmetrischen hydrierung, das sich für die herstellung von cycloalkanindolderivaten eignet - Google Patents
Verfahren zur asymmetrischen hydrierung, das sich für die herstellung von cycloalkanindolderivaten eignetInfo
- Publication number
- ATE384046T1 ATE384046T1 AT05732832T AT05732832T ATE384046T1 AT E384046 T1 ATE384046 T1 AT E384046T1 AT 05732832 T AT05732832 T AT 05732832T AT 05732832 T AT05732832 T AT 05732832T AT E384046 T1 ATE384046 T1 AT E384046T1
- Authority
- AT
- Austria
- Prior art keywords
- cycloalkanindole
- derivatives
- production
- hydrogenation process
- asymmetric hydrogenation
- Prior art date
Links
- 238000009876 asymmetric hydrogenation reaction Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B53/00—Asymmetric syntheses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Indole Compounds (AREA)
- Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55897204P | 2004-04-02 | 2004-04-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE384046T1 true ATE384046T1 (de) | 2008-02-15 |
Family
ID=34964828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05732832T ATE384046T1 (de) | 2004-04-02 | 2005-03-29 | Verfahren zur asymmetrischen hydrierung, das sich für die herstellung von cycloalkanindolderivaten eignet |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7576118B2 (de) |
| EP (1) | EP1737820B1 (de) |
| JP (1) | JP5239071B2 (de) |
| CN (1) | CN1942440B (de) |
| AR (1) | AR048459A1 (de) |
| AT (1) | ATE384046T1 (de) |
| AU (1) | AU2005230897B2 (de) |
| BR (1) | BRPI0509384A (de) |
| CA (1) | CA2561632A1 (de) |
| CY (1) | CY1107223T1 (de) |
| DE (1) | DE602005004393T2 (de) |
| DK (1) | DK1737820T3 (de) |
| ES (1) | ES2297695T3 (de) |
| HR (1) | HRP20080145T3 (de) |
| PL (1) | PL1737820T3 (de) |
| PT (1) | PT1737820E (de) |
| SI (1) | SI1737820T1 (de) |
| TW (1) | TWI344954B (de) |
| WO (1) | WO2005097745A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190004843A (ko) | 2008-07-23 | 2019-01-14 | 아레나 파마슈티칼스, 인크. | 자가면역성 및 염증성의 장애의 치료에 유용한 치환된 1,2,3,4-테트라히드로시클로펜타[ｂ]인돌-3-일)아세트산 유도체 |
| JP5726737B2 (ja) | 2008-08-27 | 2015-06-03 | アリーナ ファーマシューティカルズ， インコーポレイテッド | 自己免疫障害および免疫性障害の治療において有用なｓ１ｐ１受容体のアゴニストとしての置換三環式酸誘導体 |
| CN108558740B (zh) | 2010-01-27 | 2021-10-19 | 艾尼纳制药公司 | S1p1受体调节剂及其盐的制备方法 |
| CA2789480A1 (en) | 2010-03-03 | 2011-09-09 | Arena Pharmaceuticals, Inc. | Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
| CN102659664B (zh) * | 2012-03-28 | 2015-01-21 | 中国计量学院 | 合成分离拉洛皮兰及其类似物的方法 |
| PL3242666T3 (pl) | 2015-01-06 | 2025-02-17 | Arena Pharmaceuticals, Inc. | Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1 |
| HUE060476T2 (hu) | 2015-06-22 | 2023-03-28 | Arena Pharm Inc | (R)-2-(7-(4-ciklopentil-3-(trifluormetil)benziloxi)-1,2,3,4- tetrahidrociklopenta[B]indol-3-il)ecetsav kristályos L-arginin-sója S1P1 receptorral kapcsolatos rendellenességek esetén való alkalmazásra |
| WO2018151873A1 (en) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
| CN110545848A (zh) | 2017-02-16 | 2019-12-06 | 艾尼纳制药公司 | 用于治疗具有肠外表现的炎症性肠病的化合物和方法 |
| US12156866B2 (en) | 2018-06-06 | 2024-12-03 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
| EP3847158A1 (de) | 2018-09-06 | 2021-07-14 | Arena Pharmaceuticals, Inc. | Verbindungen zur verwendung bei der behandlung von autoimmun- und entzündlichen erkrankungen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3778857D1 (de) * | 1986-11-14 | 1992-06-11 | Takasago Perfumery Co Ltd | Katalytische produktion von optisch aktiven carbonsaeuren. |
| AR038136A1 (es) * | 2002-01-24 | 2004-12-29 | Merck Frosst Canada Inc | Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento |
| AU2004262970B2 (en) * | 2003-08-07 | 2010-03-18 | Merck Sharp & Dohme Limited | Treatment for Alzheimer's disease and related conditions |
-
2005
- 2005-03-29 AU AU2005230897A patent/AU2005230897B2/en not_active Ceased
- 2005-03-29 JP JP2007506467A patent/JP5239071B2/ja not_active Expired - Fee Related
- 2005-03-29 EP EP05732832A patent/EP1737820B1/de not_active Expired - Lifetime
- 2005-03-29 ES ES05732832T patent/ES2297695T3/es not_active Expired - Lifetime
- 2005-03-29 HR HR20080145T patent/HRP20080145T3/xx unknown
- 2005-03-29 TW TW094109815A patent/TWI344954B/zh not_active IP Right Cessation
- 2005-03-29 SI SI200530149T patent/SI1737820T1/sl unknown
- 2005-03-29 DE DE602005004393T patent/DE602005004393T2/de not_active Expired - Lifetime
- 2005-03-29 CA CA002561632A patent/CA2561632A1/en not_active Abandoned
- 2005-03-29 DK DK05732832T patent/DK1737820T3/da active
- 2005-03-29 PT PT05732832T patent/PT1737820E/pt unknown
- 2005-03-29 BR BRPI0509384-8A patent/BRPI0509384A/pt not_active IP Right Cessation
- 2005-03-29 WO PCT/US2005/010501 patent/WO2005097745A1/en not_active Ceased
- 2005-03-29 PL PL05732832T patent/PL1737820T3/pl unknown
- 2005-03-29 AT AT05732832T patent/ATE384046T1/de active
- 2005-03-29 CN CN2005800108462A patent/CN1942440B/zh not_active Expired - Fee Related
- 2005-04-01 US US11/097,565 patent/US7576118B2/en not_active Expired - Fee Related
- 2005-04-01 AR ARP050101298A patent/AR048459A1/es not_active Application Discontinuation
-
2008
- 2008-02-29 CY CY20081100240T patent/CY1107223T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US7576118B2 (en) | 2009-08-18 |
| EP1737820B1 (de) | 2008-01-16 |
| ES2297695T3 (es) | 2008-05-01 |
| SI1737820T1 (sl) | 2008-04-30 |
| CA2561632A1 (en) | 2005-10-20 |
| PT1737820E (pt) | 2008-03-17 |
| AU2005230897A1 (en) | 2005-10-20 |
| US20050222428A1 (en) | 2005-10-06 |
| CN1942440B (zh) | 2011-09-14 |
| WO2005097745A1 (en) | 2005-10-20 |
| HRP20080145T3 (en) | 2008-04-30 |
| EP1737820A1 (de) | 2007-01-03 |
| DE602005004393T2 (de) | 2009-01-08 |
| BRPI0509384A (pt) | 2007-09-18 |
| AU2005230897B2 (en) | 2011-03-03 |
| DE602005004393D1 (de) | 2008-03-06 |
| CN1942440A (zh) | 2007-04-04 |
| JP5239071B2 (ja) | 2013-07-17 |
| JP2007532488A (ja) | 2007-11-15 |
| DK1737820T3 (da) | 2008-04-28 |
| PL1737820T3 (pl) | 2008-05-30 |
| TWI344954B (en) | 2011-07-11 |
| CY1107223T1 (el) | 2012-11-21 |
| TW200606145A (en) | 2006-02-16 |
| AR048459A1 (es) | 2006-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004023921D1 (de) | Neues verfahren zur herstellung vonroflumilast | |
| EP2038375A4 (de) | Verfahren zur herstellung von grundölen | |
| DE602006009845D1 (de) | Verfahren zur herstellung von zwischenprodukten für die herstellung von ezetimibe | |
| ATE447564T1 (de) | Zwischenprodukte für die herstellung von trans-5- chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenzä , 3:6,7üoxepinoä4,5-cüpyrrol | |
| EP2073636A4 (de) | Verfahren für die herstellung von oxymorphon | |
| DE602005016292D1 (de) | Verfahren zur herstellung von glatiramer | |
| DE502004001613D1 (de) | Verfahren zur herstellung von polyamiden | |
| DE602007013512D1 (de) | Verfahren zur kontinuierlichen Herstellung von Bauteilen | |
| DE602006014558D1 (de) | Verbessertes verfahren für die herstellung von tee | |
| DE602005026987D1 (de) | Verfahren zur herstellung von 1,2-dichlorethan | |
| DE602005023046D1 (de) | Laminat, verfahren zur herstellung desselben und das laminat verwendender reifen | |
| DE602004029247D1 (de) | Verfahren zur herstellung eines olefinoxids | |
| EP1916302A4 (de) | Verfahren zur herstellung von lymphozyten | |
| DE502004005626D1 (de) | Verfahren zur herstellung von organoacylphosphiten | |
| ATE404070T1 (de) | Verfahren zur herstellung von schokoladegranulat basismaterial für die schokoladeherstellung | |
| ATE384046T1 (de) | Verfahren zur asymmetrischen hydrierung, das sich für die herstellung von cycloalkanindolderivaten eignet | |
| DE502005007762D1 (de) | Verfahren zur herstellung von zahnrädern | |
| DE502006006803D1 (de) | Verfahren zur herstellung von leder | |
| DE502005001841D1 (de) | Verfahren zur herstellung von 1,4-diphenylazetidinon-derivaten | |
| DE602005014280D1 (de) | Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten | |
| DE502005000987D1 (de) | Verfahren zur kontinuierlichen herstellung von siilicon emulsionen | |
| DE602005021110D1 (de) | Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten | |
| DE10394193D2 (de) | Verfahren zur Herstellung von Mikrosystemen | |
| DE502005007702D1 (de) | Verfahren zur herstellung von terrylen-3,4:11,12-t | |
| DE502006004187D1 (de) | Verfahren zur herstellung von diorganopolysiloxanen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1737820 Country of ref document: EP |
|
| EEFA | Change of the company name |